NASDAQ : NAUT
Nautilus Biotechnology, Inc. — Financial statements
Healthcare · Biotechnology · United States
Last price 2.73 USD (Oct 30, 2026, 4:00 PM EDT) · Market cap 347.73M
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Financial statements
Income statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Selling, General & Admin | 25.36M | 25.73M | 31.00M | 28.90M | 25.95M | 21.15M |
| Research & Development | 39.07M | 41.11M | 50.48M | 47.25M | 37.67M | 29.35M |
| Operating Expenses | 64.43M | 66.84M | 81.48M | 76.15M | 63.62M | 50.50M |
| Operating Income | -64.05M | -66.84M | -81.48M | -76.15M | -63.62M | -50.50M |
| Interest & Investment Income | 5.58M | 7.87M | 10.78M | 12.55M | 5.82M | 329.00K |
| Other Non Operating Income (Expenses) | -281.00K | -1.45M | -2.89M | -2.73M | -1.01M | 174.00K |
| EBT Excluding Unusual Items | -58.75M | -60.42M | -73.58M | -66.33M | -58.81M | -49.99M |
| Gain (Loss) on Sale of Investments | 170.00K | 1.42M | 2.80M | 2.66M | 890.00K | -183.00K |
| Gain (Loss) on Sale of Assets | -137.00K | |||||
| Pretax Income | -58.58M | -59.00M | -70.78M | -63.67M | -57.92M | -50.31M |
| Net Income | -58.58M | -59.00M | -70.78M | -63.67M | -57.92M | -50.31M |
| Net Income to Common | -58.58M | -59.00M | -70.78M | -63.67M | -57.92M | -50.31M |
| Shares Outstanding (Basic) | 126.85M | 126.26M | 125.43M | 124.92M | 124.59M | 84.46M |
| Shares Outstanding (Diluted) | 126.85M | 126.26M | 125.43M | 124.92M | 124.59M | 84.46M |
| EPS (Basic) | -0.46 | -0.47 | -0.56 | -0.51 | -0.46 | -0.60 |
| EPS (Diluted) | -0.46 | -0.47 | -0.56 | -0.51 | -0.46 | -0.60 |
| Free Cash Flow | -55.13M | -51.97M | -62.03M | -54.15M | -48.13M | -41.51M |
| Free Cash Flow Per Share | -0.43 | -0.41 | -0.49 | -0.43 | -0.39 | -0.49 |
| EBITDA | -62.76M | -65.08M | -79.42M | -74.30M | -62.40M | -49.48M |
| D&A For EBITDA | 1.29M | 1.75M | 2.06M | 1.85M | 1.22M | 1.02M |
| EBIT | -64.05M | -66.84M | -81.48M | -76.15M | -63.62M | -50.50M |
Balance sheet
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Cash & Equivalents | 10.47M | 12.39M | 27.65M | 19.40M | 114.52M | 185.62M |
| Short-Term Investments | 76.11M | 91.02M | 102.25M | 154.02M | 69.95M | 160.11M |
| Cash & Short-Term Investments | 86.58M | 103.41M | 129.89M | 173.42M | 184.47M | 345.73M |
| Prepaid Expenses | 2.76M | 2.56M | 2.93M | 3.42M | 2.74M | 3.49M |
| Total Current Assets | 90.24M | 105.96M | 132.83M | 176.84M | 187.21M | 349.22M |
| Property, Plant & Equipment | 29.86M | 31.23M | 32.33M | 36.90M | 32.57M | 31.86M |
| Long-Term Investments | 27.77M | 52.74M | 76.41M | 90.65M | 129.17M | 16.37M |
| Other Long-Term Assets | 1.06M | 1.18M | 1.18M | 1.18M | 1.11M | 997.00K |
| Total Assets | 148.92M | 191.11M | 242.74M | 305.56M | 350.05M | 398.45M |
| Accounts Payable | 1.26M | 943.00K | 987.00K | 1.64M | 1.27M | 1.72M |
| Accrued Expenses | 3.46M | 2.99M | 2.03M | 3.57M | 3.09M | 2.73M |
| Current Portion of Leases | 4.13M | 3.83M | 4.10M | 3.54M | 1.99M | 970.00K |
| Other Current Liabilities | 478.00K | 183.00K | 518.00K | 379.00K | 438.00K | 388.00K |
| Total Current Liabilities | 9.76M | 7.95M | 7.63M | 9.12M | 6.79M | 5.81M |
| Long-Term Leases | 22.61M | 26.19M | 26.38M | 31.09M | 28.34M | 29.06M |
| Total Liabilities | 32.37M | 34.14M | 34.01M | 40.21M | 35.13M | 34.87M |
| Common Stock | 13.00K | 13.00K | 13.00K | 13.00K | 12.00K | 12.00K |
| Additional Paid-In Capital | 493.94M | 488.74M | 481.68M | 467.83M | 455.33M | 444.39M |
| Retained Earnings | -376.82M | -332.02M | -273.02M | -202.24M | -138.56M | -80.64M |
| Comprehensive Income & Other | -572.00K | 243.00K | 57.00K | -255.00K | -1.85M | -184.00K |
| Total Common Equity | 116.56M | 156.97M | 208.73M | 265.35M | 314.92M | 363.58M |
| Shareholders' Equity | 116.56M | 156.97M | 208.73M | 265.35M | 314.92M | 363.58M |
| Total Liabilities & Equity | 148.92M | 191.11M | 242.74M | 305.56M | 350.05M | 398.45M |
| Total Debt | 26.74M | 30.02M | 30.48M | 34.63M | 30.33M | 30.03M |
| Net Cash (Debt) | 59.84M | 73.39M | 99.42M | 138.79M | 154.14M | 315.70M |
| Net Cash Per Share | 0.47 | 0.58 | 0.79 | 1.11 | 1.24 | 3.74 |
| Filing Date Shares Outstanding | 127.37M | 126.56M | 126.15M | 125.10M | 124.87M | 124.43M |
| Total Common Shares Outstanding | 127.33M | 126.47M | 126.11M | 125.07M | 124.87M | 124.30M |
| Working Capital | 80.48M | 98.01M | 125.19M | 167.72M | 180.42M | 343.41M |
| Book Value Per Share | 0.92 | 1.24 | 1.66 | 2.12 | 2.52 | 2.92 |
| Tangible Book Value | 116.56M | 156.97M | 208.73M | 265.35M | 314.92M | 363.58M |
| Tangible Book Value Per Share | 0.92 | 1.24 | 1.66 | 2.12 | 2.52 | 2.92 |
| Machinery | 10.07M | 9.65M | 9.31M | 7.88M | 5.42M | 4.19M |
| Construction In Progress | 4.02M | 1.81M | 1.19M | 904.00K | 1.24M | 279.00K |
| Leasehold Improvements | 63.00K | 118.00K | 118.00K | 118.00K | 13.00K | 8.00K |
Cash flow statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Net Income | -58.58M | -59.00M | -70.78M | -63.67M | -57.92M | -50.31M |
| Depreciation & Amortization | 5.65M | 6.46M | 6.44M | 5.71M | 3.42M | 2.84M |
| Loss (Gain) From Sale of Assets | 137.00K | |||||
| Asset Writedown & Restructuring Costs | 760.00K | |||||
| Loss (Gain) From Sale of Investments | -170.00K | -1.42M | -2.80M | -2.66M | -890.00K | 183.00K |
| Stock-Based Compensation | 5.28M | 6.84M | 12.70M | 12.14M | 10.38M | 7.93M |
| Change in Accounts Payable | 50.00K | -69.00K | -578.00K | 393.00K | -561.00K | 1.26M |
| Change in Other Net Operating Assets | -4.71M | -3.52M | -4.88M | -3.61M | -227.00K | -1.28M |
| Operating Cash Flow | -52.48M | -50.70M | -59.15M | -51.71M | -45.81M | -39.24M |
| Capital Expenditures | -2.65M | -1.28M | -2.88M | -2.44M | -2.32M | -2.27M |
| Investment in Securities | 40.13M | 36.50M | 69.13M | -41.29M | -23.42M | -136.69M |
| Investing Cash Flow | 37.48M | 35.22M | 66.25M | -43.73M | -25.74M | -138.96M |
| Issuance of Common Stock | 1.48M | 214.00K | 1.14M | 368.00K | 562.00K | 335.58M |
| Other Financing Activities | -8.13M | |||||
| Financing Cash Flow | 1.48M | 214.00K | 1.14M | 368.00K | 562.00K | 327.45M |
| Net Cash Flow | -13.53M | -15.26M | 8.25M | -95.08M | -70.98M | 149.24M |
| Free Cash Flow | -55.13M | -51.97M | -62.03M | -54.15M | -48.13M | -41.51M |
| Free Cash Flow Per Share | -0.43 | -0.41 | -0.49 | -0.43 | -0.39 | -0.49 |
| Levered Free Cash Flow | -31.66M | -28.78M | -36.23M | -32.09M | -27.58M | -22.33M |
| Unlevered Free Cash Flow | -31.66M | -28.78M | -36.23M | -32.09M | -27.58M | -22.33M |
| Change in Working Capital | -4.66M | -3.58M | -5.46M | -3.22M | -788.00K | -22.00K |
Ratios
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Market Capitalization | 297.41M | 246.29M | 210.95M | 373.66M | 224.50M | 643.18M |
| Enterprise Value | 237.58M | 141.87M | 101.91M | 226.00M | -4.30M | 299.44M |
| Last Close Price | 2.33 | 1.95 | 1.68 | 2.99 | 1.80 | 5.18 |
| PB Ratio | 2.55 | 1.57 | 1.01 | 1.41 | 0.71 | 1.77 |
| P/TBV Ratio | 2.55 | 1.57 | 1.01 | 1.41 | 0.71 | 1.77 |
| Debt / Equity Ratio | 0.23 | 0.19 | 0.15 | 0.13 | 0.10 | 0.08 |
| Net Debt / Equity Ratio | -0.51 | -0.47 | -0.48 | -0.52 | -0.49 | -0.87 |
| Net Debt / EBITDA Ratio | 0.95 | 1.13 | 1.25 | 1.87 | 2.47 | 6.38 |
| Net Debt / FCF Ratio | 1.08 | 1.41 | 1.60 | 2.56 | 3.20 | 7.61 |
| Quick Ratio | 8.87 | 13.00 | 17.02 | 19.01 | 27.16 | 59.48 |
| Current Ratio | 9.25 | 13.32 | 17.40 | 19.39 | 27.57 | 60.09 |
| Return on Equity (ROE) | -41.01% | -32.27% | -29.86% | -21.95% | -17.07% | -22.75% |
| Return on Assets (ROA) | -22.88% | -19.26% | -18.57% | -14.52% | -10.62% | -13.06% |
| Return on Capital Employed (ROCE) | -46.00% | -36.50% | -34.70% | -25.70% | -18.50% | -12.90% |
| Earnings Yield | -19.78% | -23.96% | -33.55% | -17.04% | -25.80% | -7.82% |
| FCF Yield | -18.54% | -21.10% | -29.40% | -14.49% | -21.44% | -6.45% |
| Buyback Yield / Dilution | -0.58% | -0.66% | -0.41% | -0.27% | -47.51% | -190.36% |